Product Information

DUPIXENT 200 MG/1.14 ML SYRING is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $1771.3716 per ML under NDC 00024591801. Its NADAC has been published 280 times since Feb 17, 2021.

DUPIXENT 200 MG/1.14 ML SYRING

Dupilumab
$1771.3716per ML

Strength

200 mg/1.14mL

NDC

00024591801

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

6/17/2026

Active Ingredients

DUPILUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761055

On Market Since

10/19/2018

Pharmacological Classes

Antibodies
Monoclonal
Interleukin 4 Receptor alpha Antagonists
Interleukin-4 Receptor alpha Antagonist

Price Statistics

The NADAC for DUPIXENT 200 MG/1.14 ML SYRING has been published 280 times since Feb 17, 2021, and over the history we have for it it has risen 29.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1771.3716 per ML
All-time high$1774.7544 (May 13, 2026)
All-time low$1366.4730 (Feb 17, 2021)
52-week high$1774.7544
52-week low$1688.2989
Median price$1530.5022
Average price$1554.2110
Largest weekly change+6.0% (Jan 11, 2023)
Weeks tracked280
Tracking sinceFeb 17, 2021

Price History

1W

0.0%

1M

+0.2%

3M

-0.2%

6M

+4.8%

1Y

+4.4%

3Y

+15.7%

5Y

+29.6%

All

+29.6%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DUPIXENT 200 MG/1.14 ML SYRING?

The current National Average Drug Acquisition Cost (NADAC) for DUPIXENT 200 MG/1.14 ML SYRING, manufactured by Sanofi-Aventis U.S. LLC, is $1771.3716 per ML (NDC 00024591801), effective Jun 24, 2026.

How has the price of DUPIXENT 200 MG/1.14 ML SYRING changed over time?

Over the history we have for it, the NADAC for DUPIXENT 200 MG/1.14 ML SYRING has risen 29.6%. It has been tracked across 280 weekly CMS publications since Feb 17, 2021.

What are the highest and lowest recorded NADAC prices for DUPIXENT 200 MG/1.14 ML SYRING?

Since Feb 17, 2021, the NADAC for DUPIXENT 200 MG/1.14 ML SYRING has ranged from a low of $1366.4730 (Feb 17, 2021) to a high of $1774.7544 (May 13, 2026), with a median of $1530.5022 per ML.

Are there cheaper alternatives to DUPIXENT 200 MG/1.14 ML SYRING?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as DUPIXENT 200 MG/1.14 ML SYRING, but none are currently priced below it.

Who manufactures DUPIXENT 200 MG/1.14 ML SYRING?

DUPIXENT 200 MG/1.14 ML SYRING (NDC 00024591801) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.